Conference CE Credit Information
Activity Overview
The purpose of this activity is to enhance clinical knowledge, thus contributing to a safer practice. In addition, providers will learn critical anatomy and the latest techniques, which will lead to optimal patient outcomes.
Target Audience
This activity is designed for an audience of nurses, nurse practitioners, physicians, and physician assistants.
Learning Objectives
Upon completion of the educational activity, participants should be able to:
- Explain the structural and physiological differences in skin of color and how they impact aesthetic treatments.
- Identify and address common aesthetic concerns such as hyperpigmentation, keloids, and uneven skin tone in patients with skin of color.
- Implement culturally sensitive approaches and communication strategies to build trust and deliver personalized care to diverse patient populations.
- Recognize potential risks unique to skin of color and develop strategies to prevent and manage adverse outcomes.
- Explore a proven system to optimize cash flow, pay off debt taster, and build wealth using strategies tailored to your needs.
- Develop a customized, effective treatment plan to treat acne, as well as a plan for potential acne complications.
- Analyze a patient’s current skincare routine to identify problematic ingredients and barriers to therapeutic results.
- Discuss how to assess patients’ individual needs, preferences, and medical histories to create customized neurotoxin treatment plans for both aesthetic and medical uses.
- Describe periocular anatomy and ageing.
- Discuss the full face from top to bottom and address these two modalities.
- Explain the importance of cross-educating to patients based on your menu of services and skincare lines.
- Deliver an unmatched outcome for fine lines and wrinkles using dermal filler.
- Identify the frequency and how to customize IV drips best suited for maintaining skin health and beauty goals.
- Explain practical skills and the intricacies involved in lip augmentation.
- Outline the implementation of GLP-1 in practice, emphasizing on comprehensive consultation.
- Discuss the benefits of HRT, such as relief from menopausal symptoms, prevention of bone loss, reversal of osteoporosis and decreased risk of heart disease.
- Implement effective client segmentation strategies to identify untapped opportunities.
- Explain the role of PLLA in stimulating collagen production for the treatment of atrophic acne scars.
- Evaluate skincare lines based on the needs, preferences, and demographics of your clients, ensuring a tailored product offering.
- Explore how microneedling creates controlled micro-injuries that stimulate collagen and elastin production, leading to smoother, more youthful skin.
- Identify different categories of biostimulators and their mechanism of action.
- Describe dangers that may be associated with the use of nitrous oxide in the outpatient settings along with the importance of continuous patient monitoring and detailed patient history awareness.
- Review three of the eight principles of skin health restoration including skin barrier function, sebum control, and stimulation plus the truth of vitamin A.
- Evaluate ROI and Long-Term Impact of New Investments.
- Discuss financial options for growth.
- Describe the art of skincare education.
- Outline how to mix and combine treatments and technologies for different concerns and conditions.
- Describe the properties and mechanism of action of CaHa when used in a hyperdiluted form for biostimulatory and regenerative purposes.
- Demonstrate 5 injection techniques to decrease incidence of Vascular Adverse Events
Criteria for Success
There is a fee to participate in this activity. Statements of credit will be awarded based on the participant’s attendance. A statement of credit will be available upon completion of an online evaluation/claim credit form available at:
If you have questions about this CE activity, please contact AKH Inc at wendi@akhcme.com.
CE credit provided by AKH Inc., Advancing Knowledge in Healthcare.


Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 11.75 AMA PRA Category 1 Credit(s)â„¢. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses
Credit being awarded: 11.75 ANCC contact hours
Physician Associate
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 11.75 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Commercial Support
There is no commercial support for this activity.
DISCLOSURES
Name
Relationship
Commercial Interest
Erika Barry, NP
Georgia Cirese
Jennifer Cobbs
Bita Farrell
Leslie Fletcher
Consultant
Allergan, Crown Medical
Lauren Gardstrom
Goerge Baxter-Holder
Julie Kaplan
Stephanie Kim, BSN, RN
Kaitlyn Morrison
Jennifer Plescia
Inna Prokopenko, RN
Jessica Henderson Rhee, PA-C
Lori Robertson, NP
Kaitlin Sears
Hermine Warren, DNP, APRN, CANS, ISPAN-F, CNM
Apryl Witherspoon
Haley Wood
Dr. Jessica Halliley
N/A
Nothing to disclose
Dorothy Caputo, MA, BSN, RN, Senior Director of Continuing Education & Compliance
AKH Inc Staff and Planners
N/A
Nothing to disclose
MBC Staff and Planners
N/A
Nothing to disclose
All of the relevant financial relationships listed for these individuals have been mitigated.
Disclosures
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.
Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant’s misunderstanding of the content.